Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages

Innate Immunity

Volumn 18, Issue 2, 2012, Pages 193-203

  Nhu, Quan M ^a   Shirey, Kari Ann ^a   Pennini, Meghan E ^a   Stiltz, Jennifer ^a   Vogel, Stefanie N ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

alternative activation; anti inflammatory; macrophage; Proteinase activated receptor 2; Toll like receptor 4

Indexed keywords

ARGINASE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MANNOSE RECEPTOR; PROTEINASE ACTIVATED RECEPTOR 2; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; ENZYME ACTIVATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; BLOTTING, WESTERN; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; INDICATORS AND REAGENTS; INFLAMMATION MEDIATORS; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, PAR-2; STIMULATION, CHEMICAL; TISSUE CULTURE TECHNIQUES; TOLL-LIKE RECEPTOR 4;

MURINAE;

EID: 84858428434     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425910395044     Document Type: Article

References (51)

1. Janeway CA, Medzhitov R. Innate immune recognition. Annu Rev Immunol. 2002 ; 20: 197-216 (Pubitemid 34293424)
2. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006 ; 124: 783-801 (Pubitemid 43261452)
3. Bianchi ME. DAMPS, PAMPS and alarmins: all we need to know about danger. J Leukoc Biol. 2007 ; 81: 1-5 (Pubitemid 46028489)
4. Nhu QM, Shirey K, Teijaro JR, et al. Novel signaling interactions between proteinase-activated receptor 2 and Toll-like receptors in vitro and in vivo. Mucosal Immunol. 2010 ; 3: 29-39
5. Shpacovitch V, Feld M, Bunnett NW, Steinhoff M. Protease-activated receptors: novel PARtners in innate immunity. Trends Immunol. 2007 ; 28: 541-550
6. Wills-Karp M, Nathan A, Page K, Karp CL. New insights into innate immune mechanisms underlying allergenicity. Mucosal Immunol. 2010 ; 3: 104-110
7. Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003 ; 3: 133-146 (Pubitemid 37328691)
8. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003 ; 3: 23-35 (Pubitemid 37328697)
9. Shirey KA, Cole LE, Keegan AD, Vogel SN. Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J Immunol. 2008 ; 181: 4159-4167
10. Martinez FO, Helming L, Gordon S. Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol. 2009 ; 27: 451-483
11. Shirey K, Pletneva LM, Puche AC, et al. Control of RSV-induced lung injury by alternatively activated macrophages is IL-4Rα-, TLR4-, and IFN-β-dependent. Mucosal Immunol. 2010 ; 3: 291-300
12. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004 ; 4: 499-511 (Pubitemid 38931765)
13. Steinhoff M, Buddenkotte J, Shpacovitch V, et al. Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev. 2005 ; 26: 1-43 (Pubitemid 40209385)
14. Vergnolle N. Review article: proteinase-activated receptors-novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther. 2000 ; 14: 257-266 (Pubitemid 30145312)
15. Cocks TM, Moffatt JD. Protease-activated receptor-2 (PAR2) in the airways. Pulm Pharmacol Ther. 2001 ; 14: 183-191 (Pubitemid 32619923)
16. Rallabhandi P, Nhu QM, Toshchakov VY, et al. Analysis of proteinase-activated receptor 2 and TLR4 signal transduction: a novel paradigm for receptor cooperativity. J Biol Chem. 2008 ; 283: 24314-24325
17. Sun G, Stacey MA, Schmidt M, Mori L, Mattoli S. Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol. 2001 ; 167: 1014-1021 (Pubitemid 32660859)
18. Chung WO, Hansen SR, Rao D, Dale BA. Protease-activated receptor signaling increases epithelial antimicrobial peptide expression. J Immunol. 2004 ; 173: 5165-5170 (Pubitemid 39387799)
19. Johansson U, Lawson C, Dabare M, et al. Human peripheral blood monocytes express protease receptor-2 and respond to receptor activation by production of IL-6, IL-8, and IL-1β. J Leukoc Biol. 2005 ; 78: 967-975 (Pubitemid 41384413)
20. Kida Y, Inoue H, Shimizu T, Kuwano K. Serratia marcescens serralysin induces inflammatory responses through protease-activated receptor 2. Infect Immun. 2007 ; 75: 164-174 (Pubitemid 46047890)
21. Schmidlin F, Amadesi S, Dabbagh K, et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol. 2002 ; 169: 5315-5321 (Pubitemid 35217205)
22. Cenac N, Coelho AM, Nguyen C, et al. Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol. 2002 ; 161: 1903-1915 (Pubitemid 35265547)
23. Hansen KK, Sherman PM, Cellars L, et al. A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc Natl Acad Sci USA. 2005 ; 102: 8363-8368 (Pubitemid 40800094)
24. Chi L, Li Y, Stehno-Bittel L, et al. Interleukin-6 production by endothelial cells via stimulation of protease-activated receptors is amplified by endotoxin and tumor necrosis factor-α. J Interferon Cytokine Res. 2001 ; 21: 231-240 (Pubitemid 32679511)
25. Ostrowska E, Sokolova E, Reiser G. PAR-2 activation and LPS synergistically enhance inflammatory signaling in airway epithelial cells by raising PAR expression level and interleukin-8 release. Am J Physiol. 2007 ; 293: L1208 - L1218 (Pubitemid 350159405)
26. Uehara A, Imamura T, Potempa J, Travis J, Takada H. Gingipains from Porphyromonas gingivalis synergistically induce the production of proinflammatory cytokines through protease-activated receptors with Toll-like receptor and NOD1/2 ligands in human monocytic cells. Cell Microbiol. 2008 ; 10: 1181-1189 (Pubitemid 351524281)
27. Cocks TM, Fong B, Chow JM, et al. A protective role for protease-activated receptors in the airways. Nature. 1999 ; 398: 156-160
28. Kawabata A, Kinoshita M, Nishikawa H, et al. The protease-activated receptor-2 agonist induces gastric mucus secretion and mucosal cytoprotection. J Clin Invest. 2001 ; 107: 1443-1450 (Pubitemid 32522038)
29. Fiorucci S, Mencarelli A, Palazzetti B, et al. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis. Proc Natl Acad Sci USA. 2001 ; 98: 13936-13941 (Pubitemid 33116002)
30. Moffatt JD, Jeffrey KL, Cocks TM. Protease-activated receptor-2 activating peptide SLIGRL inhibits bacterial lipopolysaccharide-induced recruitment of polymorphonuclear leukocytes into the airways of mice. Am J Respir Cell Mol Biol. 2002 ; 26: 680-684 (Pubitemid 34557368)
31. Panina-Bordignon P, Mazzeo D, Lucia PD, et al. β2-Agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest. 1997 ; 100: 1513-1519 (Pubitemid 27425778)
32. Braun MC, Kelsall BL. Regulation of interleukin-12 production by G-protein-coupled receptors. Microbes Infect. 2001 ; 3: 99-107 (Pubitemid 32209327)
33. Pinhal-Enfield G, Ramanathan M, Hasko G, et al. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors. Am J Pathol. 2003 ; 163: 711-721 (Pubitemid 36909432)
34. McIntire FC, Sievert HW, Barlow GH, Finley RA, Lee AY. Chemical, physical, biological properties of a lipopolysaccharide from Escherichia coli K-235. Biochemistry. 1967 ; 6: 2363-2373
35. Nhu QM, Cuesta N, Vogel SN. Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2). J Endotoxin Res. 2006 ; 12: 285-295 (Pubitemid 47471340)
36. Rowe DC, McGettrick AF, Latz E, et al. The myristoylation of TRIF-related adaptor molecule is essential for Toll-like receptor 4 signal transduction. Proc Natl Acad Sci USA. 2006 ; 103: 6299-6304
37. McGuire JJ, Saifeddine M, Triggle CR, Sun K, Hollenberg MD. 2-Furoyl-LIGRLO-amide: a potent and selective proteinase-activated receptor 2 agonist. J Pharmacol Exp Ther. 2004 ; 309: 1124-1131 (Pubitemid 38669700)
38. Salkowski CA, Neta R, Wynn TA, Strassmann G, van Rooijen N, Vogel SN. Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J Immunol. 1995 ; 155: 3168-3179
39. Carl VS, Gautam JK, Comeau LD, Smith MF. Role of endogenous IL-10 in LPS-induced STAT3 activation and IL-1 receptor antagonist gene expression. J Leukoc Biol. 2004 ; 76: 735-742 (Pubitemid 39129108)
40. Porta C, Rimoldi M, Raes G, et al. Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB. Proc Natl Acad Sci USA. 2009 ; 106: 14978-14983
41. D'Agostino B, Roviezzo F, De Palma R, et al. Activation of protease-activated receptor-2 reduces airways inflammation in experimental allergic asthma. Clin Exp Allergy. 2007 ; 37: 1436-1443 (Pubitemid 47460224)
42. Shichijo M, Kondo S, Ishimori M, et al. PAR-2 deficient CD4+ T cells exhibit downregulation of IL-4 and upregulation of IFN-γ after antigen challenge in mice. Allergol Int. 2006 ; 55: 271-278 (Pubitemid 44433595)
43. Devlin MG, Gasser RB, Cocks TM. Initial support for the hypothesis that PAR2 is involved in the immune response to Nippostrongylus brasiliensis in mice. Parasitol Res. 2007 ; 101: 105-109 (Pubitemid 46669279)
44. Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002 ; 3: 673-680 (Pubitemid 34752477)
45. Briot A, Deraison C, Lacroix M, et al. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med. 2009 ; 206: 1135-1147
46. Kouzaki H, O'Grady SM, Lawrence CB, Kita H. Proteases induce production of thymic stromal lymphopoietin by airway epithelial cells through protease-activated receptor-2. J Immunol. 2009 ; 183: 1427-1434
47. Reed CE, Kita H. The role of protease activation of inflammation in allergic respiratory diseases. J Allergy Clin Immunol. 2004 ; 114: 997-1008, quiz 1009 (Pubitemid 39469133)
48. Afkhami-Goli A, Noorbakhsh F, Keller AJ, et al. Proteinase-activated receptor-2 exerts protective and pathogenic cell type-specific effects in Alzheimer's disease. J Immunol. 2007 ; 179: 5493-5503
49. Lefkowitz RJ, Shenoy SK. Transduction of receptor signals by β-arrestins. Science. 2005 ; 308: 512-517
50. Wang P, DeFea KA. Protease-activated receptor-2 simultaneously directs β-arrestin-1-dependent inhibition and Gαq-dependent activation of phosphatidylinositol 3-kinase. Biochemistry. 2006 ; 45: 9374-9385 (Pubitemid 44223242)
51. Goon Goh F, Sloss CM, Cunningham MR, Nilsson M, Cadalbert L, Plevin R. G-protein-dependent and -independent pathways regulate proteinase-activated receptor-2 mediated p65 NF-κB serine 536 phosphorylation in human keratinocytes. Cell Signal. 2008 ; 20: 1267-1274